Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer

被引：0
|
作者：
Skyler B. Johnson
James B. Yu
机构：
[1] Yale School of Medicine,Department of Therapeutic Radiology
[2] Yale School of Medicine,Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center
来源：
Current Oncology Reports | 2018年 / 20卷
关键词：
Bladder cancer; Muscle-invasive; Bladder preservation; Trimodality therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [2] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
  • [3] Current state of the art: Bladder-preserving trimodality therapy for muscle-invasive bladder cancer
    Efstathiou, Jason A.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [4] Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Konieczkowski, David J.
    Efstathiou, Jason A.
    Mouw, Kent W.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 567 - 584
  • [5] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [6] Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Coen, John J.
    Paly, Jonathan J.
    Niemierko, Andrzej
    Kaufman, Donald S.
    Heney, Niall M.
    Spiegel, Daphne Y.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    Shipley, William U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 311 - 316
  • [7] Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer
    Joung, Jae Young
    Han, Kyung Seok
    Kim, Taek Sang
    Seo, Ho Kyung
    Chung, Jinsoo
    Lee, Kang Hyun
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 598 - 603
  • [8] Impact of selection bias on outcomes in veterans with muscle-invasive bladder cancer receiving bladder preserving trimodality therapy.
    Kumar, Abhishek
    Kotha, Nikhil V.
    Nelson, Tyler J.
    Cherry, Daniel R.
    Stewart, Tyler F.
    Mckay, Rana R.
    Rose, Brent S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [10] Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough
    Winquist, Eric
    Booth, Christopher M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (24) : 2709 - +
12345